Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 18 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
Dr Evgenia Papakrivopoulou Nefro from Etterbeek, company number BE0762615285, closed financial year 2025 with a result of € 262,883 after tax. For that financial year Dr Evgenia Papakrivopoulou Nefro recorded a gross margin of € 366,873 and equity of € 430,649. Compared with financial year 2024, the result moved from € 236,976 to € 262,883. Profitable, and profit is growing. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 29, 2026.
€ 430,649
▼ 36% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 262,883
▲ 11% vs 2024
Profit after tax over the fiscal year.
€ 107,310
▼ 8% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 500,000 paid out
More than the year’s profit went to the shareholders; reserves fell.
People and assets in 2025
€ 9,583
▼ 18% vs 2024
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 4,614
▼ 54% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 3,869
▲ € 3,155 vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 156,018
▲ 38% vs 2024
Taxes, VAT and social contributions still to pay.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 269,090 | € 348,354 | € 328,873 | € 366,873 | ▲ 12% |
| Profit after taxes | € 199,896 | € 255,924 | € 236,976 | € 262,883 | ▲ 11% |
| Equity | € 421,026 | € 676,949 | € 667,767 | € 430,649 | ▼ 36% |
| Total debts | € 114,203 | € 161,312 | € 113,387 | € 592,526 | ▲ € 479,139 |
| Cash | € 110,193 | € 168,685 | € 116,389 | € 107,310 | ▼ 8% |
| Land & buildings | € 10,087 | € 20,120 | € 17,349 | € 42,540 | ▲ 145% |
| Retained profit | € 420,026 | € 675,949 | € 666,767 | € 429,649 | ▼ 36% |
| Dividend | € 800 | € 0 | € 246,159 | € 500,000 | ▲ 103% |
| Balance sheet total | € 535,229 | € 838,261 | € 781,153 | € 1,023,175 | ▲ 31% |
By gross margin, Dr Evgenia Papakrivopoulou Nefro ranks 4th of 42 companies with main activity “Activiteiten van medisch specialisten” in Etterbeek that publish figures (fiscal year 2025).
Key figures of Dr Evgenia Papakrivopoulou Nefro, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
Ask about Dr Evgenia Papakrivopoulou Nefro the way you would ask their accountant.
Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.
Connect ChatGPT or Claude for free- ChatGPT
- Claude
Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.
What happened to Dr Evgenia Papakrivopoulou Nefro?
What happened at Dr Evgenia Papakrivopoulou Nefro in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 262,883 (▲ 11% vs 2024). filed late Source: NBB ↗
- Incorporation, published in the Gazette. Source: Staatsblad ↗
- New establishment in Etterbeek. KBO
In short
From € 199,896 profit in 2022 to € 262,883 profit in 2025.
Paid € 309,569 in corporate taxes since 2022.
Best year ever: 2025, with € 262,883 profit.
Paid out € 746,959 in dividends to the owners in total.
Establishments
Establishment units
Physical locations of this company
Gérardstraat 31
1040 Etterbeek
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Similar companies in Etterbeek
Same main activity (Activiteiten van medisch specialisten), 48 active companies in Etterbeek, largest first.
€ 858,238 gross margin · 2025
€ 686,544 gross margin · 2025
€ 424,490 gross margin · 2025
€ 318,953 gross margin · 2025
€ 309,544 gross margin · 2025
PNEUMOLOGIE ET MALADIES DU SOMMEIL
€ 271,010 gross margin · 2025
Shareholders according to the Official Gazette deeds
Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.
Incorporation
Source: Deed ↗- PAPAKRIVOPOULOU Evgenia Spyridoula(oprichter) 100%
Details
- Company number
- 0762.615.285
- VAT number
- BE 0762.615.285
- Registered office
- Gérardstraat 31, 1040 Etterbeek
- Names & denominations
- Dr Evgenia Papakrivopoulou Nefro
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 28 January 2021
- Peppol
- Active · Active since 8 Dec 2025
- Activities · NACE
Activiteiten van medisch specialisten
Overige vormen van onderwijs